GPR120 modulates epileptic seizure and neuroinflammation mediated by NLRP3 inflammasome

BACKGROUND: The complex pathophysiology of epilepsy hampers the development of effective treatments. Although more than ten kinds of anti-seizures drugs (ASDs) have good effects on seizure control worldwide, about 30% of patients still display pharmacoresistance against ASDs. Neuroinflammation seems...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Zhangjin, Song, Jiaqi, Lin, Aolei, Yang, Wei, Zhang, Wenbo, Zhong, Fuxin, Huang, Lihong, Lü, Yang, Yu, Weihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137133/
https://www.ncbi.nlm.nih.gov/pubmed/35624482
http://dx.doi.org/10.1186/s12974-022-02482-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137133/
https://www.ncbi.nlm.nih.gov/pubmed/35624482
http://dx.doi.org/10.1186/s12974-022-02482-2

Ejemplares similares